Suppr超能文献

FLI-1蛋白表达的免疫组织化学检测:对132例圆形细胞肿瘤的研究,重点关注尤因肉瘤/原始神经外胚层肿瘤的CD99阳性模拟物。

Immunohistochemical detection of FLI-1 protein expression: a study of 132 round cell tumors with emphasis on CD99-positive mimics of Ewing's sarcoma/primitive neuroectodermal tumor.

作者信息

Folpe A L, Hill C E, Parham D M, O'Shea P A, Weiss S W

机构信息

Department of Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia, USA.

出版信息

Am J Surg Pathol. 2000 Dec;24(12):1657-62. doi: 10.1097/00000478-200012000-00010.

Abstract

The histologic and immunohistochemical differentiation of Ewing' s sarcoma/primitive neuroectodermal tumor (ES/PNET) from other small, blue, round cell tumors may be difficult. Despite initial promise, CD99 (MIC2) has not proven to be a specific marker. Approximately 90% of ES/PNET have a specific t(11; 22)(q24;q12) that results in fusion of the EWS and FLI-1 genes, and overexpression of FLI-1 protein. A recent study has shown immunohistochemical FLI-1 expression in five of seven of the ES/PNET cases tested. We evaluated FLI-1 expression in 132 well-characterized small, blue, round cell tumors. All tumors were immunostained for FLI-1 (1:40, Sc 356 polyclonal, Santa Cruz Biotechnology) using steam heat for epitope retrieval. Only nuclear staining was accepted as positive. Endothelial cells were strongly positive in all cases and served as an internal control. In many cases, a subset of lymphocytes also stained positive. No staining was seen in any other normal tissue. FLI-1 expression was seen in 29 of 41 (71%) ES/PNET, 7 of 8 (88%) lymphoblastic lymphomas, 0 of 8 poorly differentiated synovial sarcomas (PDSS), 0 of 32 rhabdomyosarcoma (RMS), 0 of 30 neuroblastomas, 0 of 8 esthesioneuroblastomas, 0 of 3 Wilms' tumors, 0 of 1 mesenchymal chondrosarcoma, and in 1 of 1 desmoplastic round cell tumor. This last case was known to have an EWS/WT-1 fusion. Although the EWS/FLI-1 fusion gene is specific for ES/PNET, FLI-1 protein expression is not. Significantly, the great majority of lymphoblastic lymphomas (also CD99-positive) are strongly FLI-1-positive. Immunohistochemical detection of FLI-1 may be valuable in confirming the diagnosis of ES/ PNET in cases in which molecular genetic evaluation is not feasible. FLI-1 protein expression is also helpful in distinguishing ES/PNET from other tumors that may be CD99-positive, such as PDSS and RMS. It is not surprising that some ES/ PNET are FLI-1-negative, because not all ES/PNET have the classic EWS/FLI-1, and some cases of ES/PNET may produce either low levels of protein or idiotypically different protein.

摘要

尤因肉瘤/原始神经外胚层肿瘤(ES/PNET)与其他小的、蓝色的、圆形细胞肿瘤在组织学和免疫组织化学上的鉴别可能很困难。尽管最初有希望,但CD99(MIC2)尚未被证明是一种特异性标志物。大约90%的ES/PNET具有特异性的t(11; 22)(q24;q12),导致EWS和FLI-1基因融合,以及FLI-1蛋白过表达。最近一项研究显示,在7例检测的ES/PNET病例中有5例存在免疫组织化学FLI-1表达。我们评估了132例特征明确的小的、蓝色的、圆形细胞肿瘤中FLI-1的表达。所有肿瘤均用FLI-1(1:40,Sc 356多克隆抗体,圣克鲁斯生物技术公司)进行免疫染色,采用蒸汽加热进行抗原修复。仅细胞核染色被视为阳性。内皮细胞在所有病例中均呈强阳性,作为内对照。在许多病例中,一部分淋巴细胞也呈阳性染色。在任何其他正常组织中均未观察到染色。41例ES/PNET中有29例(71%)观察到FLI-1表达,8例淋巴母细胞淋巴瘤中有7例(88%),8例低分化滑膜肉瘤(PDSS)中0例,32例横纹肌肉瘤(RMS)中0例,30例神经母细胞瘤中0例,8例嗅神经母细胞瘤中0例,3例肾母细胞瘤中0例,1例间叶性软骨肉瘤中0例,以及1例促纤维组织增生性圆形细胞肿瘤中1例。最后一例已知有EWS/WT-1融合。虽然EWS/FLI-1融合基因对ES/PNET具有特异性,但FLI-1蛋白表达并非如此。值得注意的是,绝大多数淋巴母细胞淋巴瘤(也为CD99阳性)为强FLI-1阳性。在分子遗传学评估不可行的病例中,免疫组织化学检测FLI-1可能对确诊ES/PNET有价值。FLI-1蛋白表达也有助于将ES/PNET与其他可能为CD99阳性的肿瘤,如PDSS和RMS区分开来。一些ES/PNET为FLI-1阴性并不奇怪,因为并非所有ES/PNET都有经典的EWS/FLI-1,并且一些ES/PNET病例可能产生低水平的蛋白或独特类型的蛋白。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验